Lunch and Learn: How can experimental medicine accelerate your path to candidate selection?

​Experimental medicine is a powerful approach to address questions related to the development of novel therapeutics. Its utility is not confined to the clinical development stage.

​Join us for an insightful lunch and learn session on how experimental medicine can accelerate your path to candidate selection. Professor Duncan Richards, a renowned figure in experimental medicine, will share his expertise and discuss what types of questions can be efficiently addressed by experimental medicine, including those that arise prior to first in human studies.

​

​Guest speaker:

​Professor Duncan Richards is a renowned figure in experimental medicine. He holds the prestigious Climax Professorship of Clinical Therapeutics and is the Director of the Oxford Clinical Trials Research Unit (OCTRU). His extensive background includes medical training at Oxford University, clinical roles in London, and leadership positions at GlaxoSmithKline (GSK). Professor Richards is well-regarded for his expertise in translational medicine and contributions to advancing drug development through early-phase clinical trials. He will share his insights on accelerating drug development through innovative early-phase clinical trials.